US FDA approves Takeda and Protagonist rare blood cancer drug
US FDA approved Takeda and Protagonist's drug for a rare blood cancer.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.